These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 32828292)

  • 1. RNA N6-methyladenosine demethylase FTO regulates PD-L1 expression in colon cancer cells.
    Tsuruta N; Tsuchihashi K; Ohmura H; Yamaguchi K; Ito M; Ariyama H; Kusaba H; Akashi K; Baba E
    Biochem Biophys Res Commun; 2020 Sep; 530(1):235-239. PubMed ID: 32828292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FTO suppresses glycolysis and growth of papillary thyroid cancer via decreasing stability of APOE mRNA in an N6-methyladenosine-dependent manner.
    Huang J; Sun W; Wang Z; Lv C; Zhang T; Zhang D; Dong W; Shao L; He L; Ji X; Zhang P; Zhang H
    J Exp Clin Cancer Res; 2022 Jan; 41(1):42. PubMed ID: 35090515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. m
    Wang X; Wu R; Liu Y; Zhao Y; Bi Z; Yao Y; Liu Q; Shi H; Wang F; Wang Y
    Autophagy; 2020 Jul; 16(7):1221-1235. PubMed ID: 31451060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. m
    Yang S; Wei J; Cui YH; Park G; Shah P; Deng Y; Aplin AE; Lu Z; Hwang S; He C; He YY
    Nat Commun; 2019 Jun; 10(1):2782. PubMed ID: 31239444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3.
    Niu Y; Lin Z; Wan A; Chen H; Liang H; Sun L; Wang Y; Li X; Xiong XF; Wei B; Wu X; Wan G
    Mol Cancer; 2019 Mar; 18(1):46. PubMed ID: 30922314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FTO demethylates m6A modifications in HOXB13 mRNA and promotes endometrial cancer metastasis by activating the WNT signalling pathway.
    Zhang L; Wan Y; Zhang Z; Jiang Y; Lang J; Cheng W; Zhu L
    RNA Biol; 2021 Sep; 18(9):1265-1278. PubMed ID: 33103587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysregulation of USP18/FTO/PYCR1 signaling network promotes bladder cancer development and progression.
    Song W; Yang K; Luo J; Gao Z; Gao Y
    Aging (Albany NY); 2021 Jan; 13(3):3909-3925. PubMed ID: 33461172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FTO-Dependent
    Huang H; Wang Y; Kandpal M; Zhao G; Cardenas H; Ji Y; Chaparala A; Tanner EJ; Chen J; Davuluri RV; Matei D
    Cancer Res; 2020 Aug; 80(16):3200-3214. PubMed ID: 32606006
    [No Abstract]   [Full Text] [Related]  

  • 9. NADP modulates RNA m
    Wang L; Song C; Wang N; Li S; Liu Q; Sun Z; Wang K; Yu SC; Yang Q
    Nat Chem Biol; 2020 Dec; 16(12):1394-1402. PubMed ID: 32719557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA FTO-IT1 promotes glycolysis and progression of hepatocellular carcinoma through modulating FTO-mediated N6-methyladenosine modification on GLUT1 and PKM2.
    Wang F; Hu Y; Wang H; Hu P; Xiong H; Zeng Z; Han S; Wang D; Wang J; Zhao Y; Huang Y; Zhuo W; Lv G; Zhao G
    J Exp Clin Cancer Res; 2023 Oct; 42(1):267. PubMed ID: 37840133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. m
    Liu J; Ren D; Du Z; Wang H; Zhang H; Jin Y
    Biochem Biophys Res Commun; 2018 Aug; 502(4):456-464. PubMed ID: 29842885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA N6-methyladenosine demethylase FTO promotes osteoporosis through demethylating Runx2 mRNA and inhibiting osteogenic differentiation.
    Wang J; Fu Q; Yang J; Liu JL; Hou SM; Huang X; Cao JS; Liu TL; Wang KZ
    Aging (Albany NY); 2021 Sep; 13(17):21134-21141. PubMed ID: 34496349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The tumor-suppressive effects of alpha-ketoglutarate-dependent dioxygenase FTO via N6-methyladenosine RNA methylation on bladder cancer patients.
    Yi W; Yu Y; Li Y; Yang J; Gao S; Xu L
    Bioengineered; 2021 Dec; 12(1):5323-5333. PubMed ID: 34499008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SIRT1 Regulates N
    Liu X; Liu J; Xiao W; Zeng Q; Bo H; Zhu Y; Gong L; He D; Xing X; Li R; Zhou M; Xiong W; Zhou Y; Zhou J; Li X; Guo F; Xu C; Chen X; Wang X; Wang F; Wang Q; Cao K
    Hepatology; 2020 Dec; 72(6):2029-2050. PubMed ID: 32154934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N6-methyladenosine reader protein IGF2BP1 suppresses CD8 + T cells-mediated tumor cytotoxicity and apoptosis in colon cancer.
    Peng Y; Zhang Z; Yang G; Dai Z; Cai X; Liu Z; Yun Q; Xu L
    Apoptosis; 2024 Apr; 29(3-4):331-343. PubMed ID: 37848671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recruitment of the m
    Nabeel-Shah S; Pu S; Burke GL; Ahmed N; Braunschweig U; Farhangmehr S; Lee H; Wu M; Ni Z; Tang H; Zhong G; Marcon E; Zhang Z; Blencowe BJ; Greenblatt JF
    Genome Biol; 2024 Sep; 25(1):246. PubMed ID: 39300486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA N6-methyladenosine demethylase FTO promotes pancreatic cancer progression by inducing the autocrine activity of PDGFC in an m
    Tan Z; Shi S; Xu J; Liu X; Lei Y; Zhang B; Hua J; Meng Q; Wang W; Yu X; Liang C
    Oncogene; 2022 May; 41(20):2860-2872. PubMed ID: 35422475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FTO-Dependent N
    Mathiyalagan P; Adamiak M; Mayourian J; Sassi Y; Liang Y; Agarwal N; Jha D; Zhang S; Kohlbrenner E; Chepurko E; Chen J; Trivieri MG; Singh R; Bouchareb R; Fish K; Ishikawa K; Lebeche D; Hajjar RJ; Sahoo S
    Circulation; 2019 Jan; 139(4):518-532. PubMed ID: 29997116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FTO, m
    Mauer J; Jaffrey SR
    FEBS Lett; 2018 Jun; 592(12):2012-2022. PubMed ID: 29754392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogenic and Tumor-Suppressive Functions of the RNA Demethylase FTO.
    Zuidhof HR; Calkhoven CF
    Cancer Res; 2022 Jun; 82(12):2201-2212. PubMed ID: 35303057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.